ono 1078 has been researched along with Carcinoma, Squamous Cell in 1 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakano, R | 1 |
| Oka, M | 1 |
| Nakamura, T | 1 |
| Fukuda, M | 1 |
| Kawabata, S | 1 |
| Terashi, K | 1 |
| Tsukamoto, K | 1 |
| Noguchi, Y | 1 |
| Soda, H | 1 |
| Kohno, S | 1 |
1 other study available for ono 1078 and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein.
Topics: Adenocarcinoma; ATP-Binding Cassette Transporters; Carcinoma, Squamous Cell; Chromones; Dose-Respons | 1998 |